Alfresa Holdings (Alfresa Holdings) Interest Expense : $-1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Alfresa Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alfresa Holdings's interest expense for the three months ended in Dec. 2023 was $ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alfresa Holdings's Operating Income for the three months ended in Dec. 2023 was $ 97 Mil. Alfresa Holdings's Interest Expense for the three months ended in Dec. 2023 was $ -0 Mil. Alfresa Holdings's Interest Coverage for the quarter that ended in Dec. 2023 was 436.31. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alfresa Holdings Interest Expense Historical Data

The historical data trend for Alfresa Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings Interest Expense Chart

Alfresa Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-0.91

-0.78

-0.62

-0.48

-0.88

Alfresa Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.11	-0.11	-0.14	-0.22	-0.43

Alfresa Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1 Mil.

Alfresa Holdings (GREY:ALFRY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alfresa Holdings's Interest Expense for the three months ended in Dec. 2023 was $-0 Mil. Its Operating Income for the three months ended in Dec. 2023 was $97 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $208 Mil.

Alfresa Holdings's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	96.86	/	-0.222
	=	436.31

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Alfresa Holdings Corp has enough cash to cover all of its debt. Its financial situation is stable.

Alfresa Holdings (Alfresa Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

2784:Japan

Address

1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

http://www.alfresa.com

Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines